1. What are the major restraints and supply-chain risks affecting the manual wheelchair market?
Reimbursement caps and claim denials remain the largest restraint; Medicare Part B covers only physician-certified mobility devices, and industry data shows roughly 22% of initial wheelchair claims are denied. Supply-side risks center on aluminum tubing and specialty castor wheels, with Asian component concentration extending lead times by up to eight weeks during peak procurement cycles. Regulatory divergence across EU MDR and FDA 510(k) pathways adds 10–15% to compliance overhead.




